Description
Class A61P : THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
Subclass 5/00: Drugs for disorders of the endocrine system
A61P 5/00
Sub-Class
Stats
- 92 US PATENTS IN FORCE
- 18 US APPLICATIONS PENDING
- 38 Total Patent Owners
- 1,930 TOTAL INVENTORS
Recent Patents
| Patent # | Title | Filing Date | Issue Date | Patent Owner |
|---|---|---|---|---|
| 12005065 | Corticotropin releasing factor receptor antagonists | Apr 26, 23 | Jun 11, 24 | SPRUCE BIOSCIENCES, INC. |
| 11999791 | Prevention of disulfide bond reduction during recombinant production of polypeptides | May 01, 23 | Jun 04, 24 | Genentech, Inc. |
| 11992479 | R-fadrozole for use in the treatment of aldostonerism | May 02, 19 | May 28, 24 | DAMIAN PHARMA AG |
| 11980597 | Lasofoxifene treatment of breast cancer | Mar 30, 23 | May 14, 24 | Duke University |
| 11964053 | Single-injection methods and formulations to induce and control multiple ovarian follicles in bovine, caprine, ovine, camelid and other female animals | May 31, 22 | Apr 23, 24 | THERIO, LLC |
| 11964055 | Orodispersible dosage unit containing an estetrol component | Oct 18, 21 | Apr 23, 24 | ESTETRA SRL |
| 11959486 | Stable liquid formulation of AMG 416 (etelcalcetide) | Aug 11, 21 | Apr 16, 24 | Amgen Inc. |
| 11911424 | Selection and use of melatonin supporting bacteria to reduce infantile colic | Jul 24, 19 | Feb 27, 24 | Biogaia AB |
| 11896578 | receptor | Apr 20, 21 | Feb 13, 24 | Arena Pharmaceuticals, Inc. |
| 11845715 | Sulfonylureas and related compounds and use of same | Aug 18, 21 | Dec 19, 23 | The University of Queensland; The Provost, Fellows, Foundation Scholars, and the other members of Board, of the College of the Holy and Undivided Trinity of Queen Elizabeth, near Dublin; |
| 11833228 | Fluorinated beta-hydroxybutyric acids for PET imaging | Aug 13, 20 | Dec 05, 23 | The Governors of the University of Alberta |
| 11827684 | Human interleukin-2 conjugates biased for the interleukin-2 receptor beta GAMMAc dimer and conjugated to a nonpeptidic, water-soluble polymer | Apr 20, 21 | Nov 28, 23 | Merck Sharp & Dohme LLC |
| 11793760 | Orodispersible dosage unit containing an estetrol component | May 12, 23 | Oct 24, 23 | ESTETRA SRL |
| 11793812 | Methods of treating endometriosis | May 11, 21 | Oct 24, 23 | Sumitomo Pharma Switzerland GmbH; Takeda Pharmaceutical Company Limited; |
| 11773097 | Polymorphs of sepiapterin and salts thereof | Jun 09, 21 | Oct 03, 23 | PTC Therapeutics MP, Inc. |
| 11758928 | Compositions and methods that modulate phosphorus or enzymes in a companion animal | Dec 12, 17 | Sep 19, 23 | Société des Produits Nestlé S.A. |
| 11759464 | Gonadotropin-releasing hormone antagonist dosing regimens for treating uterine fibroids and reducing menstrual blood loss | Jun 05, 18 | Sep 19, 23 | Kissei Pharmaceutical Co. Ltd. |
| 11753638 | Conjugated oligonucleotides | Aug 11, 17 | Sep 12, 23 | The General Hospital Corporation and University of Massachusetts |
| 11752106 | Pharmaceutical composition and administrations thereof | Sep 15, 21 | Sep 12, 23 | Vertex Pharmaceuticals Incorporated |
| 11464816 | Supplement for menopause | Oct 26, 20 | Oct 11, 22 | The Procter & Gamble Company |
Recent Publications
| Publication # | Title | Filing Date | Pub Date | Patent Owner |
|---|---|---|---|---|
| 2024/0180,870 | METHODS OF TREATING CONDITIONS RELATED TO THE S1P1 RECEPTOR | Jan 08, 24 | Jun 06, 24 | Arena Pharmaceuticals, Inc. |
| 2024/0115,729 | COMPOSITIONS AND METHODS FOR TARGETED ANTIFIBROTIC THERAPY IN CHRONIC PANCREATITIS | Feb 04, 22 | Apr 11, 24 | University of Virginia Patent Foundation |
| 2024/0084,297 | CONJUGATED OLIGONUCLEOTIDES | Feb 16, 23 | Mar 14, 24 | Not available |
| 2024/0041,944 | OPTIMIZED INDIVIDUALIZED PREBIOTIC COMPOSITIONS | Mar 09, 23 | Feb 08, 24 | Not available |
| 2024/0034,762 | Compositions and Methods For Inhibiting FGF23 Activity | Sep 02, 21 | Feb 01, 24 | Not available |
| 2024/0024,330 | CRF RECEPTOR ANTAGONISTS AND METHODS OF USE | Aug 25, 21 | Jan 25, 24 | Not available |
| 2023/0405,157 | MELANOCORTIN TYPE 2 RECEPTOR (MC2R) TARGETED THERAPEUTICS AND USES THEREOF | May 08, 23 | Dec 21, 23 | Not available |
| 2023/0330,095 | PHARMACEUTICAL COMPOSITION FOR ANTI-CANCER COMPRISING NUPR1 ISOFORM A INHIBITOR | Apr 13, 23 | Oct 19, 23 | Not available |
| 2023/0020,626 | COMPOSITIONS AND METHODS FOR TREATING OBESITY AND HYPERPHAGIA | Jun 24, 22 | Jan 19, 23 | Not available |
| 2022/0143,037 | CORTICOTROPIN RELEASING FACTOR RECEPTOR ANTAGONISTS | Jan 27, 22 | May 12, 22 | Not available |
| 2022/0073,527 | TYK2 INHIBITORS AND USES THEREOF | Sep 17, 21 | Mar 10, 22 | Not available |
| 2020/0215,034 | AUTOTAXIN INHIBITORS AND USES THEREOF | Mar 17, 20 | Jul 09, 20 | Not available |
| 2019/0192,664 | COLLOIDAL PARTICLES FOR USE IN MEDICINE | Oct 14, 16 | Jun 27, 19 | Not available |
| 2018/0147,185 | AUTOTAXIN INHIBITORS AND USES THEREOF | May 24, 16 | May 31, 18 | PHARMAKEA, INC. |
| 2018/0133,194 | METHOD OF TREATING INFLAMMATION USING NATURAL COMPOUNDS AND/OR DIET | Jun 27, 16 | May 17, 18 | Not available |
| 2018/0098,963 | LASOFOXIFENE TREATMENT OF BREAST CANCER | Oct 10, 17 | Apr 12, 18 | Not available |
| 2011/0287,040 | MATERIALS AND METHODS FOR TREATMENT OF INFLAMMATION | May 23, 11 | Nov 24, 11 | Cytogel Pharma, LLC |
| 2010/0255,059 | Artificial micro-gland | Mar 17, 10 | Oct 07, 10 | MARQUEZ, MANUEL, MARQUEZ, SAMANTHA M., MS, |
Top Owners in This Subclass
| Upgrade to the Professional Level to view Top Owners for this Subclass.Learn More |
|---|
Patents Issued To Date - By Filing Year
Average Time to Issuance
- 33 Months (last 2 years Issuances)
- 33 Months (last 5 years Issuances)